Literature DB >> 30059015

Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Michael N Sack.   

Abstract

Remodeling of mitochondrial metabolism plays an important role in regulating immune cell fate, proliferation, and activity. Furthermore, given their bacterial ancestry, disruption in mitochondrial fidelity leading to extravasation of their content initiates and amplifies innate immune surveillance with a myriad of physiologic and pathologic consequences. Investigations into the role of mitochondria in the immune system have come to the fore, and appreciation of mitochondrial function and quality control in immune regulation has enhanced our understanding of disease pathogenesis and identified new targets for immune modulation. This mitochondria-centered Review focuses on the role of mitochondrial metabolism and fidelity, as well as the role of the mitochondria as a structural platform, for the control of immune cell polarity, activation, and signaling. Mitochondria-linked disease and mitochondrially targeted therapeutic strategies to manage these conditions are also discussed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30059015      PMCID: PMC6118630          DOI: 10.1172/JCI120845

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  167 in total

1.  Mitochondrial permeability transition triggers the release of mtDNA fragments.

Authors:  M Patrushev; V Kasymov; V Patrusheva; T Ushakova; V Gogvadze; A Gaziev
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

2.  Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2α dephosphorylation by the GADD34/PP1c complex.

Authors:  Jessica Perego; Andreia Mendes; Clarisse Bourbon; Voahirana Camosseto; Alexis Combes; Hong Liu; Thien-Phong Vu Manh; Alexandre Dalet; Lionel Chasson; Lionel Spinelli; Nathalie Bardin; Laurent Chiche; Manuel A S Santos; Evelina Gatti; Philippe Pierre
Journal:  Sci Signal       Date:  2018-01-23       Impact factor: 8.192

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 4.  Dendritic cell metabolism.

Authors:  Edward J Pearce; Bart Everts
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

5.  Up-regulation of mitofusin-2 protects CD4+ T cells from HMGB1-mediated immune dysfunction partly through Ca(2+)-NFAT signaling pathway.

Authors:  Guang-ju Zhao; Yong-ming Yao; Zhong-qiu Lu; Guang-liang Hong; Xiao-mei Zhu; Yao Wu; Da-wei Wang; Ning Dong; Yan Yu; Zhi-yong Sheng
Journal:  Cytokine       Date:  2012-04-30       Impact factor: 3.861

6.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

7.  Mitofusin 2 inhibits mitochondrial antiviral signaling.

Authors:  Kai Yasukawa; Hiroyuki Oshiumi; Makoto Takeda; Naotada Ishihara; Yusuke Yanagi; Tsukasa Seya; Shun-ichiro Kawabata; Takumi Koshiba
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

8.  NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.

Authors:  Simona Granata; Valentina Masola; Elisa Zoratti; Maria Teresa Scupoli; Anna Baruzzi; Michele Messa; Fabio Sallustio; Loreto Gesualdo; Antonio Lupo; Gianluigi Zaza
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Autophagy maintains the metabolism and function of young and old stem cells.

Authors:  Theodore T Ho; Matthew R Warr; Emmalee R Adelman; Olivia M Lansinger; Johanna Flach; Evgenia V Verovskaya; Maria E Figueroa; Emmanuelle Passegué
Journal:  Nature       Date:  2017-03-01       Impact factor: 49.962

10.  A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.

Authors:  Maria Laura Avantaggiati; Ferdinando Palmieri; Vittoria Infantino; Vito Iacobazzi; Alessio Menga
Journal:  Biochim Biophys Acta       Date:  2014-07-27
View more
  11 in total

1.  Effects of Immunosuppressive Medications on Mitochondrial Function.

Authors:  Amanda Nash; Mariya Samoylova; Tess Leuthner; Minghua Zhu; Liwen Lin; Joel N Meyer; Todd V Brennan
Journal:  J Surg Res       Date:  2020-01-06       Impact factor: 2.192

2.  Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.

Authors:  Bo Zhou; Dennis Ding-Hwa Wang; Yanhua Qiu; Sophia Airhart; Yaxin Liu; April Stempien-Otero; Kevin D O'Brien; Rong Tian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 3.  Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop

Authors:  Rong Tian; Wilson S. Colucci; Zoltan Arany; Markus M. Bachschmid; Scott W. Ballinger; Sihem Boudina; James E. Bruce; David W. Busija; Sergey Dikalov; Gerald W. Dorn; Zorina S. Galis; Roberta A. Gottlieb; Daniel P. Kelly; Richard N. Kitsis; Mark J. Kohr; Daniel Levy; E. Douglas Lewandowski; Joseph M. McClung; Daria Mochly-Rosen; Kevin D. O'Brien; Brian O'Rourke; Joon-Young Park; Peipei Ping; Michael N. Sack; Shey-Shing Sheu; Yang Shi; Sruti Shiva; Douglas C. Wallace; Robert G. Weiss; Hilary J. Vernon; Renee Wong; Lisa Schwartz Longacre
Journal:  Circulation       Date:  2019-10-01       Impact factor: 29.690

Review 4.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

Review 5.  The emerging roles of GCN5L1 in mitochondrial and vacuolar organelle biology.

Authors:  Kaiyuan Wu; Iain Scott; Lingdi Wang; Dharendra Thapa; Michael N Sack
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-06-26       Impact factor: 4.490

Review 6.  Mitochondrial Bioenergetics and Dynamics in Secretion Processes.

Authors:  Jennyfer Martínez; Inés Marmisolle; Doménica Tarallo; Celia Quijano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

7.  A Mitochondrial Polymorphism Alters Immune Cell Metabolism and Protects Mice from Skin Inflammation.

Authors:  Paul Schilf; Axel Künstner; Michael Olbrich; Silvio Waschina; Beate Fuchs; Christina E Galuska; Anne Braun; Kerstin Neuschütz; Malte Seutter; Katja Bieber; Lars Hellberg; Christian Sina; Tamás Laskay; Jan Rupp; Ralf J Ludwig; Detlef Zillikens; Hauke Busch; Christian D Sadik; Misa Hirose; Saleh M Ibrahim
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

8.  The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Zhihong Yuan; Kuo-Chuan Lin; Joanna B Goldberg; C Michael Hart; Kristina L Bailey; Ruxana T Sadikot
Journal:  Pathogens       Date:  2022-01-19

9.  Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.

Authors:  Jing Wu; Komudi Singh; Amy Lin; Allison M Meadows; Kaiyuan Wu; Vivian Shing; Maximilian Bley; Shahin Hassanzadeh; Rebecca D Huffstutler; Mark S Schmidt; Luz P Blanco; Rong Tian; Charles Brenner; Mehdi Pirooznia; Mariana J Kaplan; Michael N Sack
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 19.456

Review 10.  Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

Authors:  Noemi Rotllan; Mercedes Camacho; Mireia Tondo; Elena M G Diarte-Añazco; Marina Canyelles; Karen Alejandra Méndez-Lara; Sonia Benitez; Núria Alonso; Didac Mauricio; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve
Journal:  Antioxidants (Basel)       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.